Takahata, Keisuke http://orcid.org/0000-0002-0884-4924
Seki, Chie
Kimura, Yasuyuki
Kubota, Manabu
Ichise, Masanori
Sano, Yasunori
Yamamoto, Yasuharu
Tagai, Kenji
Shimada, Hitoshi
Kitamura, Soichiro
Matsuoka, Kiwamu
Endo, Hironobu
Shinotoh, Hitoshi
Kawamura, Kazunori
Zhang, Ming-Rong
Takado, Yuhei
Higuchi, Makoto
Article History
Received: 14 October 2021
Accepted: 26 December 2021
First Online: 13 January 2022
Change Date: 11 April 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00259-022-05795-9
Declarations
:
: This study was approved by the Radiation Drug Safety Committee, and the Institutional Review Board of National Institutes for Quantum Science and Technology, Chiba, Japan, and was carried out in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. After complete description of the study, written informed consent was obtained from all participants.
: Written informed consent was obtained from all participants regarding publishing their data.
: MH has received grant support from Takeda Pharmaceutical Company Limited. All other authors declare that they have no conflicts of interest. The precursor and reference standard of <sup>18</sup>F-T-401 for the present study were provided by Takeda Pharmaceutical Company Limited. This study was supported in part by a Grant-in-Aid for Scientific Research C (20K07935), a grant from the General Insurance Association of Japan (2020–2021) to KT, a Grants-in-Aid for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS; 21dm0207072h0003), Strategic International Brain Science Research Promotion Program (Brain/MINDS Beyond; 20dm0307105h0002), JST Grant Number JPMJMS2024, and AMED Grant Number 20356533 to MH.